Download presentation
Presentation is loading. Please wait.
Published byBarbara Koenig Modified over 6 years ago
1
Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host Disease of the Gastrointestinal Tract Drew J. Winston, Lindsey R. Baden, Don A. Gabriel, Christos Emmanouilides, Leslie M. Shaw, W. Robert Lange, Voravit Ratanatharathorn Biology of Blood and Marrow Transplantation Volume 12, Issue 6, Pages (June 2006) DOI: /j.bbmt Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Mean plasma ganciclovir concentration over time after dosing with 900 mg of oral valganciclovir or 5 mg/kg of intravenous ganciclovir. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions
3
Figure 2 Mean plasma valganciclovir concentration over time after dosing with 900 mg of oral valganciclovir. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.